IMGN Overview
Upcoming Projects (IMGN)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (IMGN)
-
Discussing the CD123 from Immunogen, Pivekimab Sunirine, and its potential in AML when used in combination with azacitidine and/or venetoclax
Ticker: IMGN
Executed On: Nov 22, 2023 at 10:00 AM EST -
Discussing the PICCOLO study data on ImmunoGen's Elahere in recurrent platinum-sensitive ovarian cancer
Ticker: IMGN
Executed On: Nov 03, 2023 at 09:00 AM EDT -
Discussing the ASCO data from the MIRASOL trial of Immunogen's ELAHERE in patients with platinum-resistant ovarian cancer
Ticker: IMGN
Executed On: Jun 08, 2023 at 09:00 AM EDT -
Discussing Antibody Drug Conjugates for ovarian cancer with a focus on Immunogen's ELAHERE in advance of the upcoming MIRASOL confirmatory trial data & Mersana's Upifitamab Rilsodotin (UpRi)
Tickers: IMGN, MRSN, STRO
Executed On: Mar 17, 2023 at 01:00 PM EDT -
A Second Perspective: Discussing ImmunoGen's drug Mirvetuximab Soravtansine in treating ovarian cancer
Ticker: IMGN
Executed On: Feb 28, 2022 at 04:00 PM EST -
Discussing ImmunoGen's drug Mirvetuximab Soravtansine in treating ovarian cancer
Ticker: IMGN
Executed On: Feb 17, 2022 at 03:00 PM EST
Expired Projects (IMGN)
-
Analyzing ImmunoGen’s mirvetuximab in FRalpha,-high platinum-resistant ovarian cancer
Ticker: IMGN
Execute By: Jan 19, 2022
Upcoming & Overdue Catalysts (IMGN)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (IMGN)
-
ImmunoGen Announces Proposed $100 Million Offering of Convertible Senior Notes Due 2021
Ticker: IMGN
Occurred on: Jun 13, 2016 -
ImmunoGen Announces Initiation of Clinical Testing of First-in-Class IMGN779 for Acute Myeloid Leukemia
Ticker: IMGN
Occurred on: Apr 18, 2016
Strategic Initiatives (IMGN)
